Delivery Order SPE2DR25D2003-SPE2DR26FR04K
- Not listed
- The Defense Logistics Agency awarded a $1,256.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on May 23, 2025, with a completion date of May 27, 2025. This non-set-aside competitive award was placed for performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $2,315.52 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100 count) on November 12, 2025, with completion targeted for November 13, 2025. This firm fixed-price contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract is non-set-aside and was competitively awarded, reflecting...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,438.70 for OxyContin ER 20 mg tablets (100-count) on December 10, 2025, with a completion date of December 11, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,733.21 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 25, 2025, with ultimate completion by August 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across...
- The Defense Logistics Agency awarded a $2,335.74 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) on December 12, 2025, with completion targeted for December 15, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $10,091.11 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on November 20, 2025, with an ultimate completion date of November 21, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,225.00 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100 count) with a completion date of November 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency (DLA) awarded a $1,166.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) on December 2, 2025, with an ultimate completion date of December 3, 2025. The order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,451.16 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $2,166.03 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) with a firm fixed price and an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR04KDelivery Order
The Defense Logistics Agency awarded a $1,195.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of OxyContin ER 20 mg, with an ultimate completion date of December 19, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The award reflects the company's established role as a critical pharmaceutical distributor supporting military and federal healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical solutions provider to the federal government with extensive experience delivering brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic categories. The company's substantial IDC with DLA positions it to fulfill diverse pharmaceutical requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities globally. This particular delivery order for controlled-release pain management medication demonstrates the breadth of medical commodities supplied under the broader DLA pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/17/25 |